Site Search

Share

X

Search Results

2024 West Virginia Legislative Priorities

... for all insurance plans, including traditional Medicaid, to provide a comprehensive benefit for lung cancer screening including all follow-up testing according to recommended guidelines, without enrollee cost sharing or other barriers. Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

Cancer Advocates Urge Lawmakers to Help Reduce the Cancer Burden on Minnesotans

... coverage options and help Minnesotans facing serious diseases, like cancer, better manage and plan for their prescription drug costs. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Biomarker testing is an important step to accessing precision medicine that can lead to improved survivorship and better quality ...

Legislative Action Needed to Reduce the Burden of Cancer

... is asking the legislature to prioritize access to care for cancer patients through the expansion of telehealth services and increased access to biomarker testing. Telehealth is critical because it provides cancer patients and survivors with a convenient means of accessing some cancer care and primary ... ‘the right treatment, to the right patient, at the right time,’ precision medicine plays a critical role in improving cancer outcomes, and biomarker testing is an essential step to precision medicine. Legislative action on these pieces of legislation would improve access to care for ...

Courage in Action: Cancer Survivors Unite at State Capitol to Advocate for Change

... home for cancer patients and their caregivers. Advocates also met with lawmakers to ask them to support legislation that would improve access to biomarker testing. This legislation will help address a significant barrier and bring the promise of precision medicine to more Ohioans, no matter their income or where they live. Biomarker testing opens the door to targeted therapies, which can provide many benefits to patients, including better outcomes, improved quality of ...

2025 New Jersey Legislative Priorities

... Network (ACS CAN) will work with the New Jersey Legislature on legislative and regulatory efforts that provide affordable, adequate access to biomarker testing, ensure adequate appropriations funding for lifesaving cancer screening programs, and enact prevention policies that help people who use ... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care  Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes ...

2025 New Jersey Cancer Action Week

... state leaders to discuss our cancer legislative and budget priorities.  Cancer Action Week Legislative Asks: Expand coverage and access to biomarker testing. Pass copay accumulator legislation (S3818/A5217), which would improve access to prescription drugs by ensuring copay assistance is counted ... Maintain funding for the New Jersey Cancer Education and Early Detection Screening Program (NJCEED) at $5 Million. Event Resources: New Jersey Biomarker one pager New Jersey Step Therapy Copay Accumulator  New Jersey Commission on Cancer Research  New Jersey Cancer Education and Early ...

Two Pieces to the Puzzle: Innovation and Access

... innovation needs to be considered from the genesis of targeted therapies. It’s well-documented that patients are missing key opportunities for biomarker testing, which looks for specific mutations of a cancer to determine the most effective therapy for their particular cancer. As we have learned ... is reaching every patient.  It’s equally important to consider patient access to targeted therapies. Assuming a patient has had appropriate biomarker testing, patient access to the therapies indicated by this testing is another potential barrier. Our health care system has to find ways ...

2023 Kentucky Legislative Priorities

... products. We will be making the following fact-based policies a priority and ask for your support:   Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for House Bill 180, which improves coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

Governor Murphy Sets Sights on Affordability Concerns in 2025, Advocates Applaud & Urge Lawmakers to Prioritize Patients across Cancer Continuum

... barriers that inhibit people from completing the screening process.   Helping patients avoid ineffective treatment through increased access to biomarker testing: “Biomarker testing provides doctors with information about what treatment their patients will best respond to, helping patients more effectively and ...

Legislative Action Needed to Reduce the Burden of Cancer on New Jerseyans

... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy